NEW YORK (360Dx) – Rosetta Genomics this week announced an agreement to make the RosettaGX Reveal thyroid miRNA classifier and its other testing services accessible through MediNcrease Health Plans’ regional and national health plans, insurance companies, employers, and other parties. MediNcrease is a national provider network and provider advocacy firm.

Sophia Genetics said that six leading healthcare institutions from across Mexico have adopted Sophia artificial intelligence, which provides clinical genomics solutions for cancer and congenital disorders. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.